Where Chinese Investors Meet Global Investment News and Opportunities

中國投資者探索環球投資新聞及機遇

Cannmart Signs Product Acquisition Agreement with AgMedica Bioscience Inc

VANCOUVER, Nov. 7, 2018 /CNW/ – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”), has signed a product acquisition agreement (the “Agreement”) with AgMedica Bioscience Inc. (“AgMedica”), whereby Cannmart will purchase medical cannabis from AgMedica to offer in its online platform. AgMedica is a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), who hold a cultivation and sales license.

Subject to the terms of the Agreement, Cannmart has placed its first order with AgMedica, and will be launching AgMedica products in its online medical cannabis marketplace. Cannmart will offer AgMedica products pre-packed in 5g, 10g, and 15g allocations. The Company’s goal is for Cannmart to offer patients a unique user-experience and a variety of cannabis products and strains sourced from multiple licensed producers.

Cannmart is in the process of adding new products as well as a selection of pre-rolls which will be available in each strain. With hundreds of new cultivators in various stages of the application process, Cannmart provides a platform for licensed producers to offer their products alongside those of other brands in an online marketplace.

The Company has been pleased with the initial results after launching medical cannabis sales through Cannmart, and has also expanded its healthcare practitioner team through the Company’s wholly-owned subsidiary, NamasteMD Inc. (“NamasteMD”) to accommodate accelerating demand for consultations. The Company is pleased to have secured an additional supply channel through the Agreement with AgMedica and is focused on developing further channels to expand on the product offering through Cannmart.com.

Management Commentary

Sean DollingerPresident, and CEO of Namaste comments: “We’re pleased to announce this supply Agreement with AgMedica. Our team from Cannmart had the pleasure of visiting their facility and we were impressed with the quality of their product and we look forward to offering it to our patients. We expect to develop a long-term relationship with AgMedica and would like to thank their management team for their hard work and for choosing Cannmart as a strategic partner.”

About AgMedica Bioscience Inc.

AgMedica is a licensed producer under the ACMPR and is focused on the cultivation of quality, consistent medical cannabis. The company’s Riverview cultivation facility is located in Chatham, Ontario. The Phase I facility has annual capacity of 6,000 kg of indoor cannabis. Plans are in place to expand this capacity within the existing building to 26,500kg. The company’s second indoor facility is in the detailed review stage at Health Canada to become an ACMPR licensed producer and is forecast to add an additional 40,000 kg in annual capacity once fully built, providing AgMedica with a total projected indoor production capacity of 66,500 kg per year.

About Namaste Technologies Inc.

Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste’s product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and medical cannabis in the Canadian market.

Namaste has developed and acquired innovative technology platforms including NamasteMD.com, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer’s on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 604-355-6100
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.

Do NOT follow this link or you will be banned from the site!